Search - tctmd.com

Displaying 121 - 140 of 156

Sort: Relevancy | Date

News Conference News ACC 2021

REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay

Caitlin E. Cox

May 16, 2021

News Conference News ACC 2021

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Shelley Wood

May 16, 2021

News Conference News ACC 2021

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

L.A. McKeown

May 15, 2021

News Conference News ACC 2021

‘Enormous’ QoL Improvements With Mavacamten in HCM

Shelley Wood

May 15, 2021

News Daily News

FDA Approves Dapagliflozin for CKD Patients

Michael O'Riordan

May 03, 2021

News Opinion CV Team Dispatch

May 2021 News Roundup

L.A. McKeown

May 01, 2021

News Conference News EHRA 2021

His-Bundle Pacing Gains Support in Pilot Study

Todd Neale

April 28, 2021

News Daily News

New HF Uncommon After COVID-19, but Rare Cases Pose Quandary

Shelley Wood

April 28, 2021

News Daily News

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

Michael O'Riordan

April 26, 2021

News Conference News EHRA 2021

RACE 3: Effects Wane for Targeted Therapy in Early AF, HF

Todd Neale

April 26, 2021

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

News Daily News

Pneumonia in HF Patients Is Common, Lethal, and Preventable

L.A. McKeown

April 19, 2021

News Daily News

FDA: Another Class I Recall for HeartWare VAD

Shelley Wood

April 16, 2021

News Daily News

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

Michael O'Riordan

April 15, 2021

News Opinion CV Team Dispatch

April 2021 News Roundup

L.A. McKeown

April 10, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2021

Shelley Wood

April 02, 2021

News Daily News

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Michael O'Riordan

April 02, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Daily News

Patient-Reported Outcomes Beat NYHA Class for Tracking Gains in HFrEF

L.A. McKeown

March 25, 2021

News Daily News

Women Treated for Acute HF Report Worse QoL Than Men

Caitlin E. Cox

March 12, 2021

Advertisement

REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

‘Enormous’ QoL Improvements With Mavacamten in HCM

FDA Approves Dapagliflozin for CKD Patients

May 2021 News Roundup

His-Bundle Pacing Gains Support in Pilot Study

New HF Uncommon After COVID-19, but Rare Cases Pose Quandary

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

RACE 3: Effects Wane for Targeted Therapy in Early AF, HF

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Pneumonia in HF Patients Is Common, Lethal, and Preventable

FDA: Another Class I Recall for HeartWare VAD

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

April 2021 News Roundup

TCTMD’s Top 10 Most Popular Stories for March 2021

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Roughly 80% of ESC Guideline Writers Have Financial COIs

Patient-Reported Outcomes Beat NYHA Class for Tracking Gains in HFrEF

Women Treated for Acute HF Report Worse QoL Than Men

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content